Why are immunotherapies so effective as treatments for melanoma?

One of the chief reasons that immunotherapies have a much better chance of helping someone with a melanoma skin cancer compared to other cancers (like ovarian or cervical cancer) is that they have so many more neoantigens on their surface.

Neoantigens are peptides (fragments) from mutated proteins, and our immune system is constantly on the lookout for them.

If a cell contains lots of DNA mutations (such as a skin cancer cell damaged by UV light from the sun), it will be making lots of mutated proteins. When it recycles these proteins*, fragments of them end up on the cell’s surface.

*Cells are constantly making and then chopping up and recycling proteins.

Now, you might think that a cancer caused by a virus, such as cervical cancer, might also be a good target for immunotherapy. After all, our immune system is on the lookout for viruses too.

But, sadly, chronic human papillomavirus (HPV) infection is associated with a suppressed immune system, not just inside the tumour, but throughout the whole body. There might be ways to overcome this. But, for now, immunotherapy for cervical cancer in the form of immune checkpoint inhibitors has given relatively modest results.

Endometrial cancer, where a large proportion contain tens of thousands of mutations due to either microsatellite instability or a defect in a DNA polymerase enzyme, is much more sensitive to immunotherapy.